We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,624

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDRE icon
13251
PUT
Cadre Holdings
CDRE
$1.46B
$6.58K ﹤0.01%
200
+100
+100% +$3.02K
SPIB icon
13252
CALL
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$6.57K ﹤0.01%
+200
New +$6.36K
BNED icon
13253
CALL
Barnes & Noble Education
BNED
$421M
$6.56K ﹤0.01%
44
-70
-61% -$7.78K
GABC icon
13254
PUT
German American Bancorp
GABC
$1.93B
$6.48K ﹤0.01%
200
-2,200
-92% -$64.2K
HCAT icon
13255
PUT
Health Catalyst
HCAT
$139M
$6.48K ﹤0.01%
700
-15,500
-96% -$127K
DSKE
13256
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$6.48K ﹤0.01%
800
-187,600
-100% -$908K
NBP
13257
PUT
NovaBridge Biosciences American Depositary Shares
NBP
$227M
$6.46K ﹤0.01%
3,400
-9,300
-73% -$13.9K
PEGRW
13258
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$6.46K ﹤0.01%
258,386
-44,883
-15% -$2.78K
BCTX
13259
PUT
Briacell Therapeutics
BCTX
$29.9M
$6.43K ﹤0.01%
+7
New +$5.02K
SES icon
13260
PUT
SES AI
SES
$223M
$6.41K ﹤0.01%
3,500
+500
+17% +$1.08K
KPTI icon
13261
PUT
Karyopharm Therapeutics
KPTI
$45.8M
$6.4K ﹤0.01%
493
-287
-37% -$3.87K
RIGL icon
13262
PUT
Rigel Pharmaceuticals
RIGL
$795M
$6.38K ﹤0.01%
440
-420
-49% -$4.29K
MRCC
13263
PUT
DELISTED
Monroe Capital Corp
MRCC
$6.36K ﹤0.01%
900
-2,600
-74% -$18.4K
SEIC icon
13264
PUT
SEI Investments
SEIC
$12.8B
$6.36K ﹤0.01%
100
-900
-90% -$52.5K
CMRX
13265
CALL
DELISTED
Chimerix, Inc.
CMRX
$6.35K ﹤0.01%
6,600
+1,700
+35% +$1.65K
MDXG icon
13266
MiMedx Group
MDXG
$622M
$6.35K ﹤0.01%
724
-116,692
-99% -$854K
MIST icon
13267
PUT
Milestone Pharmaceuticals
MIST
$137M
$6.35K ﹤0.01%
3,800
PPTA
13268
CALL
Perpetua Resources
PPTA
$3.16B
$6.34K ﹤0.01%
2,000
+1,400
+233% +$4.72K
XNET
13269
CALL
Xunlei
XNET
$334M
$6.32K ﹤0.01%
3,900
-4,400
-53% -$6.86K
NDLS icon
13270
PUT
Noodles & Co
NDLS
$107M
$6.3K ﹤0.01%
250
-2,613
-91% -$57.1K
LPL icon
13271
CALL
LG Display
LPL
$3.5B
$6.27K ﹤0.01%
1,300
ATLX icon
13272
CALL
Atlas Lithium Corp
ATLX
$94.7M
$6.26K ﹤0.01%
+200
New +$5.18K
BB icon
13273
BlackBerry
BB
$5.22B
$6.25K ﹤0.01%
1,764
-36,257
-95% -$136K
SWI
13274
PUT
DELISTED
SolarWinds Corporation Common Stock
SWI
$6.25K ﹤0.01%
500
-300
-38% -$3.23K
DHX icon
13275
CALL
DHI Group
DHX
$171M
$6.22K ﹤0.01%
2,400
+2,000
+500% +$5.15K

Similar funds

Ken Griffin's Q4 2023 Portfolio in Review

As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
  • Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.